by admin | Jun 19, 2025 | English
– If approved, Zemcelpro® is expected to: increase access to donor-derived stem cell transplantation, which offers a potentially curative option for haematologic malignancies, including leukemias and myelodysplastic syndromes be the first and only therapy in the...
by admin | Jun 4, 2024 | English
– UM171 Cell Therapy has been granted an International Nonproprietary Name (INN) of “dorocubicel” on the INN Recommended List issued by the World Health Organization (WHO) – The U.S. Food and Drug Administration (FDA) has granted UM171 Cell Therapy...
by admin | Nov 3, 2023 | English
MONTREAL, November 3, 2023 – ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and fitness, announced today several UM171 presentations, including an oral session on new data from Phase 2 studies of investigational UM171 cell therapy in...
by admin | Aug 8, 2023 | English
MONTREAL, August 8, 2023 – Cordex Biologics Inc., an ExCellThera Company, announced today the recent publication in Blood Advances from the American Society of Hematology of results from a safety and efficacy retrospective analysis comparing outcomes of patients...
